LU84358A1 - Formulations pharmaceutiques de pro-insuline humaine - Google Patents

Formulations pharmaceutiques de pro-insuline humaine Download PDF

Info

Publication number
LU84358A1
LU84358A1 LU84358A LU84358A LU84358A1 LU 84358 A1 LU84358 A1 LU 84358A1 LU 84358 A LU84358 A LU 84358A LU 84358 A LU84358 A LU 84358A LU 84358 A1 LU84358 A1 LU 84358A1
Authority
LU
Luxembourg
Prior art keywords
insulin
human
pro
proinsulin
units
Prior art date
Application number
LU84358A
Other languages
English (en)
French (fr)
Inventor
Bruce Hill Frank
Ronald Eugene Chance
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU84358A1 publication Critical patent/LU84358A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
LU84358A 1981-08-27 1982-08-26 Formulations pharmaceutiques de pro-insuline humaine LU84358A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27
US29675281 1981-08-27

Publications (1)

Publication Number Publication Date
LU84358A1 true LU84358A1 (fr) 1983-02-28

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84358A LU84358A1 (fr) 1981-08-27 1982-08-26 Formulations pharmaceutiques de pro-insuline humaine

Country Status (21)

Country Link
JP (1) JPS5846023A (de)
AU (1) AU552054B2 (de)
BE (1) BE894186A (de)
CA (1) CA1176160A (de)
CH (1) CH650677A5 (de)
DE (1) DE3232036A1 (de)
FR (1) FR2511866B1 (de)
GB (1) GB2104380B (de)
HU (1) HU193522B (de)
IE (1) IE53829B1 (de)
IL (1) IL66610A (de)
IT (1) IT1153184B (de)
LU (1) LU84358A1 (de)
MW (1) MW3782A1 (de)
MY (1) MY8700757A (de)
NL (1) NL8203316A (de)
NZ (1) NZ201683A (de)
PH (1) PH18716A (de)
SE (1) SE8204871L (de)
ZA (1) ZA826157B (de)
ZW (1) ZW17382A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
GB2104380A (en) 1983-03-09
IE53829B1 (en) 1989-03-15
ZA826157B (en) 1984-04-25
JPS5846023A (ja) 1983-03-17
NZ201683A (en) 1985-08-16
DE3232036A1 (de) 1983-03-10
PH18716A (de) 1985-09-11
IE822062L (en) 1983-02-27
IL66610A0 (en) 1982-12-31
GB2104380B (en) 1984-12-05
IT8223019A0 (it) 1982-08-27
CA1176160A (en) 1984-10-16
IL66610A (en) 1985-11-29
SE8204871D0 (sv) 1982-08-25
HU193522B (en) 1987-10-28
SE8204871L (sv) 1983-02-28
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
MW3782A1 (en) 1984-06-13
CH650677A5 (de) 1985-08-15
ZW17382A1 (en) 1982-11-17
FR2511866A1 (fr) 1983-03-04
NL8203316A (nl) 1983-03-16
IT8223019A1 (it) 1984-02-27
FR2511866B1 (fr) 1986-08-14
MY8700757A (en) 1987-12-31
AU552054B2 (en) 1986-05-22
AU8759582A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
Chinookoswong et al. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.
BE1009408A5 (fr) Formulations d'analogues de l'insuline.
US7381702B2 (en) Methods of treating diabetes mellitus
FR2511867A1 (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaines
JPH0196137A (ja) 真性糖尿病の治療
LU84359A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
US20040038867A1 (en) Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
FR2511866A1 (fr) Formulations pharmaceutiques de pro-insuline humaine
LU84357A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine
MC1099A1 (fr) Médicament à base d'un polypeptide
US20120270778A1 (en) Compositions and Methods for Non-Invasive Treatment of Chronic Complications of Diabetes
Servais et al. ECYSCO: A European Cohort dedicated to cystinosis
RU2219894C2 (ru) Способ лечения сахарного диабета у детей и подростков
FR2746313A1 (fr) Utilisation de la melatonine et des ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention et au traitement du diabete et des complications diabetiques
BE1013507A5 (fr) Formulations d'analogues de l'insuline.
KR20200130297A (ko) 비만의 치료 및 체중 관리를 위한 glp-1 조성물
Sherwin et al. Metabolic Effects of IGF-I: Implications for the Therapy of Diabetes Mellitus